WALTHAM, Mass. - Fresenius Medical Care North America, a provider of kidney dialysis clinics and renal products, is presenting research abstracts about dialysis treatment, patient care and outcomes during the American Society of Nephrology's annual meeting.
Renal Week 2010, the largest scientific gathering of kidney disease experts worldwide, takes place Nov. 16-21 in Denver. This year's theme is "Advancing Science and Medicine to Improve Kidney Health." Attendance of more than 13,000 is expected, including more than 10,000 scientists and clinicians.
The conference will provide a forum to discuss the latest findings in renal research and engage in educational sessions related to advances in the care of patients with kidney and related disorders. FMCNA contributes research to ASN each year regarding the management of its patient population, to further the advancement of kidney care.
Founded in 1966, the American Society of Nephrology (ASN) is the world's largest professional society devoted to the study of kidney disease. Comprised of 11,000 physicians and scientists, ASN continues to promote expert patient care, to advance medical research, and to educate the renal community. ASN also informs policymakers about issues of importance to kidney doctors and their patients. ASN funds research, and through its world-renowned meetings and first-class publications, disseminates information and educational tools that empower physicians.
Fresenius Medical Care, through nearly 2,600 clinics in North America, Europe, Latin America, Asia-Pacific and Africa, provides kidney dialysis treatments to approximately 199,000 patients worldwide. The company, which has a plant in Ogden, makes dialysis products such as hemodialysis machines, dialyzers and related disposable products. Chronic kidney failure is a condition that affects about 1.9 million individuals worldwide and the only treatments are a kidney transplant or dialysis.